Plasma neuronal specific enolase: A potential stage diagnostic marker in human African trypanosomiasis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 108, Issue 7, 2014, Pages 449-452

  Sternberg, Jeremy M ^a   Mitchell, Julia A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

African trypanosomiasis; Neuronal specific enolase; Stage

Indexed keywords

BIOLOGICAL MARKER; NEURON SPECIFIC ENOLASE; ENOLASE;

AFRICAN TRYPANOSOMIASIS; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NOTE; TRYPANOSOMA RHODESIENSE; CASE CONTROL STUDY; CEREBROSPINAL FLUID; EPIDEMIOLOGY; RETROSPECTIVE STUDY; TRYPANOSOMIASIS, AFRICAN; UGANDA;

BIOMARKERS; CASE-CONTROL STUDIES; HUMANS; PHOSPHOPYRUVATE HYDRATASE; RETROSPECTIVE STUDIES; TRYPANOSOMIASIS, AFRICAN; UGANDA;

EID: 84902479292     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/tru065     Document Type: Note

References (24)

1. Sternberg JM, Maclean L. A spectrum of disease in human African trypanosomiasis: the host and parasite genetics of virulence. Parasitology 2010;137:2007-15.
2. Lejon V, Rosengren LE, Buscher P et al. Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients. Am J Trop Med Hyg 1999;60:94-8.
3. Lejon V, Legros D, Rosengren L et al. Biological data and clinical symptoms as predictors of astrogliosis and neurodegeneration in patients with second-stage Trypanosoma brucei gambiense sleeping sickness. Am J Trop Med Hyg 2001;65:931-5.
4. Sternberg JM, Rodgers J, Bradley B et al. Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. J Neuroimmunol 2005;167:81-9.
5. Kennedy PG. Diagnositc and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 2006;36:505-12.
6. Bacchi CJ. Chemotherapy of human african trypanosomiasis. Interdiscip Perspect Infect Dis 2009:195040.
7. Lejon V, Buscher P. Review article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health 2005;10:395-403.
8. Hainard A, Tiberti N, Robin X et al. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Negl Trop Dis 2009;3:e459.
9. Simarro PP, Jannin J, Cattand P. Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 2008;5:e55.
10. Guzel A, Er U, Tatli M. Serum neuron-specific enolase as a predictor of short-term outcome and its correlation with Glasgow Coma Scale in traumatic brain injury. Neurosurg Rev 2008;31:439-44; discussion 444-35.
11. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 2003;21:79-96.
12. Wunderlich MT, Lins H, Skalej M et al. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg 2006;108:558-63.
13. Gelderblom M, Daehn T, Schattling B et al. Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis. Neurobiol Dis 2013;59:177-82.
14. MacLean LM, Odiit M, Chisi JE et al. Focus-specific clinical profiles in human African trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 2010;4:e906.
15. WHO. Control and surveillance of African trypanosomiasis. Geneva: World Health Organization Tech Rep Ser 1998;881:1-113.
16. MacLean L, Odiit M, Okitoi D, Sternberg JM. Plasma nitrate and interferon-gamma in Trypanosoma brucei rhodesiense infections: evidence that nitric oxide production is induced during both early blood-stage and late meningoencephalitic-stage infections. Trans R Soc Trop Med Hyg 1999;93:169-70.
17. Westgard JO. Basic Method Validation. Madison: Wesgtgard Publications; 2003.
18. Frenchik MD, McFaul SJ, Tsonev LI. A microplate assay for the determination of hemoglobin concentration. Clin Chim Acta 2004;339:199-201.
19. Koch M, Mostert J, Heersema D et al. Plasma S100beta and NSE levels and progression in multiple sclerosis. J Neurol Sci 2007;252:154-8.
20. Ramont L, Thoannes H, Volondat A et al. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 2005;43:1215-17.
21. Royds JA, Davies-Jones GA, Lewtas NA et al. Enolase isoenzymes in the cerebrospinal fluid of patients with diseases of the nervous system. J Neurol Neurosurg Psychiatry 1983;46:1031-6.
22. Cunningham RT, Young IS, Winder J et al. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991;21:497-500.
23. Mokuno K, Kato K, Kawai K et al. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983;60:443-51.
24. Quan N, Mhlanga JD, Whiteside MB et al. Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei. J Comp Neurol 1999;414:114-30.